Reviews in Endocrine and Metabolic Disorders

{{short description|Medical review journal}}

{{Infobox journal

| title = Reviews in Endocrine and Metabolic Disorders

| image =

| caption =

| former_name =

| abbreviation = Rev. Endocr. Metab. Disord.

| discipline = Endocrinology

| editor = Felipe F. Casanueva

| publisher = Springer Science+Business Media

| country =

| history = 2000–present

| frequency = Quarterly

| openaccess =

| license =

| impact = 9.306

| impact-year = 2021

| ISSN = 1389-9155

| eISSN = 1573-2606

| CODEN = REMDCG

| JSTOR =

| LCCN =

| OCLC = 299338864

| website = https://link.springer.com/journal/11154

| link2 = https://link.springer.com/journal/volumesAndIssues/11154

| link2-name = Online archive

}}

Reviews in Endocrine and Metabolic Disorders is a quarterly peer-reviewed medical review journal covering endocrinology and metabolism. It was established in 2000 with Derek LeRoith as the founding editor-in-chief.{{Cite journal |last=Koch |first=Christian A. |last2=Zitzmann |first2=Michael |date=September 2015 |title=Introduction to: Endocrinological aspects of andrology—what is new? |journal=Reviews in Endocrine and Metabolic Disorders |volume=16 |issue=3 |pages=175 |doi=10.1007/s11154-015-9324-1 |pmid=26682567 |doi-access=free }} It is published by Springer Science+Business Media and the editor-in-chief is Felipe F. Casanueva (University of Santiago de Compostela). According to the Journal Citation Reports, the journal has a 2021 impact factor of 9.306.{{cite book |year=2022 |chapter=Reviews in Endocrine and Metabolic Disorders |title=2021 Journal Citation Reports |publisher=Clarivate |edition=Science |series=Web of Science |title-link=Journal Citation Reports}}